Bio/Pharma News

Jan 30, 2013
ePT--the Electronic Newsletter of Pharmaceutical Technology
Endo Pharmaceuticals and GVK Biosciences (GVK BIO), a contract research organisation (CRO) based in India, have entered into an agreement to collaborate on the development of small molecules targeting an undisclosed protein. Using its discovery expertise, GVK BIO will deliver a clinical candidate and Endo will be responsible for the development and commercialisation of the product.
Jan 29, 2013
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
Ben Venue Laboratories announced that it has voluntarily entered into a consent decree with FDA over violations of cGMP.
Jan 28, 2013
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
GlaxoSmithKline has formed a joint venture with Indian vaccines company Biological E to research and develop a six-in-one combination pediatric vaccine to help protect children in India and other developing countries from certain infectious diseases.
Jan 25, 2013
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
Following its recent acquisition, Actavis (formerly Watson Pharmaceuticals) unveiled its long-term growth strategy during its investor meeting in New York.
Jan 25, 2013
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
AstraZeneca and Ceram Research, a materials development company based in the UK, have signed an agreement whereby Ceram will develop its inorganic-based controlled release technology in a feasibility study for delivering select AstraZeneca compounds.
Jan 24, 2013
ePT--the Electronic Newsletter of Pharmaceutical Technology
Allergan and MAP Pharmaceuticals have entered into a definite merger agreement under which Allergan will purchase all of MAP?s outstanding shares for the price of $25.00 per share.
Jan 16, 2013
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
FDA has issued a Warning Letter to Hameln Pharmaceuticals GmbH after observing "significant" cGMP violations for finished pharmaceuticals at the company?s facility in Hameln, Germany.
Jan 09, 2013
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
A roundup of developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
Jan 08, 2013
ePT--the Electronic Newsletter of Pharmaceutical Technology
Eli Lilly expects overall revenue growth in the coming year.
Jan 07, 2013
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
AbbVie, a research-focused, specialty biopharmaceutical company that was spun off from Abbott Pharmaceuticals, was officially launched on Jan. 2, 2013
native1_300x100
lorem ipsum